Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.
暂无分享,去创建一个
Rakesh K Jain | R. Jain | L. Munn | D. McDonald | Diane E. Capen | E. di Tomaso | Lance L Munn | A. Haskell | Donald M McDonald | Emmanuelle di Tomaso | Amy Haskell | Diane Capen | Janet Hart | James J Logie | Rosemary Jones | Rosemary C. Jones | J. Logie | Janet Hart
[1] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[2] D. McDonald,et al. Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.
[3] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[4] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.
[5] Gavin Thurston,et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. , 2004, The American journal of pathology.
[6] H. Dvorak,et al. Ultrastructural Localization of Platelet Endothelial Cell Adhesion Molecule (PECAM-1, CD31) in Vascular Endothelium , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[7] D. McDonald,et al. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.
[8] M. F. Booth,et al. What brings pericytes to tumor vessels? , 2003, The Journal of clinical investigation.
[9] D. Newton,et al. "Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. , 2003, Cancer research.
[10] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[11] L. Munn,et al. Aberrant vascular architecture in tumors and its importance in drug-based therapies. , 2003, Drug discovery today.
[12] M. Hendrix,et al. The Clinical Significance of Tumor Cell-Lined Vasculature in Ovarian Carcinoma: Implications for Anti-Vasculogenic Therapy , 2002, Cancer biology & therapy.
[13] A. Griesmacher,et al. Variation of adhesion molecule expression on human umbilical vein endothelial cells upon multiple cytokine application. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[14] Peter Bohlen,et al. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. , 2002, Cancer research.
[15] D. Chaplin,et al. Influence of hypoxia and tumour-conditioned medium on endothelial cell adhesion molecule expression in vitro. , 2002, Anticancer research.
[16] Rakesh K Jain,et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.
[17] R. Jain,et al. Vascular Morphogenesis and Remodeling in a Human Tumor Xenograft: Blood Vessel Formation and Growth After Ovariectomy and Tumor Implantation , 2001, Circulation research.
[18] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.
[19] E. Manseau,et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. , 2001, The American journal of pathology.
[20] R K Jain,et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] Peter Bohlen,et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity , 2000 .
[22] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[23] J. Folkman,et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. , 2000, Cancer research.
[24] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.
[25] S. Baruchel,et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. , 2000, The Journal of clinical investigation.
[26] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[27] S. White,et al. Microvessel precursor smooth muscle cells express head-inserted smooth muscle myosin heavy chain (SM-B) isoform in hyperoxic , 1999, Cell and Tissue Research.
[28] S. Kumar,et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. , 1999, Cancer research.
[29] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] R K Jain,et al. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.
[31] M. Barcos,et al. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] G. Sephel,et al. Expression of capillary basement membrane components during sequential phases of wound angiogenesis. , 1996, Matrix biology : journal of the International Society for Matrix Biology.
[33] L. Leach,et al. Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. , 1995, Microvascular research.
[34] R. Jain,et al. Tissue-isolated human tumor xenografts in athymic nude mice. , 1994, Microvascular research.
[35] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[36] R. Jones. Ultrastructural analysis of contractile cell development in lung microvessels in hyperoxic pulmonary hypertension. Fibroblasts and intermediate cells selectively reorganize nonmuscular segments. , 1992, The American journal of pathology.
[37] K. Messmer,et al. The fine structure of tumor blood vessels. I. Participation of non-endothelial cells in tumor angiogenesis. , 1985, International journal of microcirculation, clinical and experimental.
[38] P. Shubik,et al. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. , 1966, Laboratory investigation; a journal of technical methods and pathology.